Skip to content

Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma

Development of a Machine Learning-based Model for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03198975
Enrollment
40
Registered
2017-06-26
Start date
2017-06-23
Completion date
2017-07-31
Last updated
2017-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Keywords

magnetic resonance image features, pathological differentiation, machine learning-based model

Brief summary

Microvascular invasion (MVI) has been well demonstrated as an unfavorable prognostic factor for hepatocellular carcinoma (HCC), and patients with MVI have a high risk of tumor recurrence after curative hepatectomy. Currently, the diagnosis of MVI is determined on the postoperative histologic examination, which greatly limits its influence on preoperative decision making. Therefore, we constructed this prospective study to develop a machine learning-based model for preoperative prediction of MVI by extracting high-dimensional magnetic resonance (MR) image features.

Detailed description

Histologically-diagnosed primary HCC after curative hepatectomy. The magnetic resonance image will be imported into the imaging management software (GE healthcare Analysis-Kit software),and the tumor lesions will manually delineated by two independent radiologists and then reconstruct into three-dimensional images for feature extraction. The radiomic textural features including grayscale histogram, transform matrix, wavelet transform and filter transformation are automatically extracted by the Analysis-Kit software.The high-throughput extracted features will be then selected by the univariate analysis, and a prediction model will be developed based on machine learning algorithm in a training set in which patients were collected from a retrospective study. And in the present study, an independent validation set will be collected and used to validate the prediction accuracy of the model.

Interventions

Histologically-diagnosed primary HCC after curative hepatectomy. The magnetic resonance image will be imported into the software ,and the radiomic textural features will be automatically extracted by the Analysis-Kit software.The high-throughput extracted features will be then selected and a prediction model will be developed in the training set in which patients were collected from a retrospective study. In this project, an independent validation set will be collected and used to validate the prediction accuracy of the model.

Sponsors

Ming Kuang
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Asian patients aged 18~80 years old; * HCC without macroscopic vascular invasion according to imaging findings; * Child Pugh A-B stage; * Receipt of preoperative Gd-EOB-DTPA enhanced MR imaging of the abdomen within one month before surgery; * Histologically-diagnosed primary HCC after curative hepatectomy;

Exclusion criteria

* Combined hepatocellular-cholangiocarcinoma; * With extra-hepatic metastasis or macrovascular invasion; * With incomplete clinical and imaging data; * Non-radical resection;

Design outcomes

Primary

MeasureTime frameDescription
Presence of microvascular invasionThrough patient enrollment completion ,an average of 2 yearsPostoperative histologically confirmed microvascular invasion

Countries

China

Contacts

Primary ContactZebin Chen, MD
chenzebin_2008@126.com+86 13316284086
Backup ContactJie Mei, MD
mmjj0926@163.com+86 15817089979

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026